Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. - sprookjes - yvandenbroek - TriplyDB

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

http://www.wikidata.org/entity/Q34159304

about

Positron emission tomography imaging of prostate cancer Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene Preclinical molecular imaging of tumor angiogenesis.Molecular imaging of vessels in mouse models of disease.18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos).Combination of an Integrin-Targeting NIR Tracer and an Ultrasensitive Spectroscopic Device for Intraoperative Detection of Head and Neck Tumor Margins and Metastatic Lymph Nodes.Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes.Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.A One-Pot Three-Component Double-Click Method for Synthesis of [67Cu]-Labeled Biomolecular Radiotherapeutics.Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.Imaging of VEGF receptor in a rat myocardial infarction model using PET High-affinity peptide against MT1-MMP for in vivo tumor imaging Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein.Peptides and peptide hormones for molecular imaging and disease diagnosis Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.Positron emission tomography molecular imaging for drug development.PET of malignant melanoma using 18F-labeled metallopeptides.Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression Quantitative cardiovascular magnetic resonance for molecular imaging.Tetraspecific ligand for tumor-targeted delivery of nanomaterials.A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.Immuno-PET imaging of tumor endothelial marker 8 (TEM8)FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Are quantum dots ready for in vivo imaging in human subjects?Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging Positron emission tomography imaging of cancer biology: current status and future prospects

P2860

Q24596241-E8080EE0-1AE7-479E-9FA5-3DEC7D04D862 Q26771417-1C477EB2-A4DE-425D-8C2F-B138FF66BB23 Q26801806-F2E1C449-4CBB-4905-BB1C-28A9489A8FFB Q27023605-66C23B76-74F2-42D1-A6AB-1390F6A23503 Q28072021-94B0ECAA-BBBB-44F1-8B30-C273AB79C755 Q28729872-328C06FA-0546-40A3-AC8B-F5102743B7FD Q28817842-66D6E62B-36CA-496C-9810-E65AE5844BB1 Q30475818-E5DEE847-A80F-4A96-88D6-FB7852AE7C0C Q30481645-4A4DE4A5-6C40-41EA-8DFC-56F436E910C3 Q30497615-581B8EE1-C568-4502-A285-F90F31B8BBCA Q30524330-E362AF72-F305-430E-A227-53275524312F Q30528528-F9C4D042-2124-4C1D-9BD9-E530BA0F5EE0 Q30820507-63609FC2-1A72-4B7E-A224-9D69C3A12270 Q33358260-9C7A1148-4900-480E-87B9-1D6E27D43F63 Q33387746-E490BBB0-94FB-4559-9671-9841560D09C7 Q33447473-A10CA818-A760-483D-A9D3-93EA71189BBD Q33581665-F5B61DA5-A1E8-4CED-9FA4-DD9A9EC98ED8 Q33689501-48D59705-5D57-45E4-BB6A-8AE701A5BFEA Q33708506-7609B539-5DDF-487A-8848-ED62FB91B27E Q33786497-7E0AB89F-5129-4A5D-AAB0-02383A11E4E2 Q33812205-D36B4687-D1C2-4FBD-AB52-925BD7D2AA89 Q33833584-E5486791-92D1-40F5-9797-1B044DADD445 Q33846924-0815C6E1-8E10-46B8-95B3-E79AC19B3769 Q33867187-4C8A1B3D-6FCF-4897-8B32-2C52CF7A50C3 Q33925952-42E9FF9F-D745-42DD-A789-A183292C0AF8 Q33956262-0A17C814-21C3-4959-B434-21AE380F400C Q33991881-5452D27F-9D9A-46C2-B744-14109E33933B Q34062271-EB3F98C7-3D80-480F-A7EF-7395DD6DFC3D Q34134418-697F89E9-9A0D-43D8-AA21-F993C01813C0 Q34205400-ED428F53-FEAA-4F1B-9CAA-F071D1AB75E7 Q34282774-65569B6A-157C-4BBD-A658-F5EFCC09E0DC Q34282895-1590601A-B207-4120-B459-1F4B38E735E6 Q34330885-C7E0DCAA-E1DB-413F-AB58-7A4E7BE19802 Q34380877-F9C8C438-0F52-4C76-A764-264BF92DD2AF Q34419762-EF71A78F-1E75-42C3-8F8A-6D1555A8D8F1 Q34473434-5F2254C5-D091-4C4C-A558-885C7B273165 Q34556242-219A2D1B-A54E-4C8C-AAF9-7CD73FB59AE9 Q34632573-D88242E8-F3FE-4A23-A38B-075A376DB947 Q34662001-8314752D-E25B-4903-B590-5375A02454D9 Q34697688-8A7D971A-13E2-491B-AF67-DDE0C3E49DD0

P2860

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

http://www.wikidata.org/entity/Q34159304

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@ast

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@en

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@nl

type

label

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@ast

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@en

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@nl

prefLabel

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@ast

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@en

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@nl

P1433

Q34159304-E154D19D-166B-4F52-8045-65CC80B7A0BF

P1476

Q34159304-E4E866CD-03B1-455E-AB80-70172E7A1D35

P2093

Q34159304-0D27F4AE-3805-42CB-80BF-8CADBA86921E

Q34159304-56EE105D-5468-43C9-AE62-8F6D5C216E28

Q34159304-8D7C7ABC-813E-4917-83B3-04C803CE1A6B

Q34159304-C8E0A6F0-0535-4823-A1D6-ECE8113DEFE8

Q34159304-D079107A-9F33-406E-BCBC-12E757AC7785

Q34159304-F4A28696-7A23-4585-BB2B-21B93504671D

P2860

Q34159304-0CD5FCC1-8728-42B9-9304-98237AFD2D44

Q34159304-0ED13185-F749-447E-B362-487194D3895B

Q34159304-17164161-09E2-4033-9075-2C58DAD4033D

Q34159304-1C3ACF9A-4E21-4D29-B074-258CD2B5B3C2

Q34159304-20EE6C4D-CAE1-435D-82C9-80594E6B5F38

Q34159304-241825BB-FF49-4855-BCC5-0B11761EB033

Q34159304-36690209-E858-43C6-B95D-E0DBDF19EC0D

Q34159304-61E1D9E9-F11E-4E0A-89C8-7F74B280BEAB

Q34159304-62D8026A-8516-4D5F-B1DA-B725C0F05CB0

Q34159304-66FC2CDF-45F4-4F7D-91B5-C2BCD19609BD

P304

Q34159304-42C543C8-1B4C-42DC-BA48-122553F96885

P31

Q34159304-7030833C-7376-4539-890D-E09E761BC70C

P407

Q34159304-D6DCF8CE-182B-4C61-9BBE-8E64BF73A65C

P433

Q34159304-06A6AD0A-F7F8-48A0-86CD-68710F08942A

P478

Q34159304-FEDA995A-7B89-4A37-B8D9-E319F0777EE5

P50

Q34159304-A0DC8E46-AE32-4C44-B715-076E724B4A0B

P577

Q34159304-23101C50-25C6-4BF0-9311-63604D6048D6

P698

Q34159304-926EDD9D-F4EB-4483-82C6-7D08CE01C806

P932

Q34159304-381A81D1-330A-4F32-B9CB-8C80DE1FE60C

P1433

The Journal of Nuclear Medicine

P1476

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

@en

P2093

Jeffery R Tseng

http://www.w3.org/2001/XMLSchema#string

Sanjiv S Gambhir

http://www.w3.org/2001/XMLSchema#string

Weibo Cai

http://www.w3.org/2001/XMLSchema#string

Xianzhong Zhang

http://www.w3.org/2001/XMLSchema#string

Yun Wu

http://www.w3.org/2001/XMLSchema#string

Zhengming Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

Integrins: bidirectional, allosteric signaling machines

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins.

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells.

Graphical analysis of PET data applied to reversible and irreversible tracers.

New insight into the analysis of 6-[18F]fluoro-L-DOPA PET dynamic data in brain tissue without an irreversible compartment: comparative study of the Patlak and Logan analyses.

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

P304

113-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16391195

http://www.w3.org/2001/XMLSchema#string

P932

4160026

http://www.w3.org/2001/XMLSchema#string